Ads
related to: thalassemia beta minor treatment side effects- Find Treatment Centers
Find an Authorized Treatment Center
By Using the Map Search Feature.
- Prescribing Information
View Full Prescribing Information &
Indications And Usage.
- Treatment Journey
Learn More About Treatment And
See If It's Right for Your Patients
- Safety and Side Effects
Review the Safety Profile
And Potential Side Effects.
- Important Safety Info
View Warnings And Precautions.
Understand the Potential Risks.
- HCP Resources
Download Treatment Brochures,
Billing Codes, and More.
- Find Treatment Centers
Search results
Results From The WOW.Com Content Network
Dietary indicaxanthin has been shown to have protective effects on RBCs in people with beta thalassemia. [26] It has a structure similar to that of amino acids, and is amphiphilic: it is able to bind to cell membranes through charge-related interactions with polar head groups of membrane constituents, as well through adsorption to the lipid ...
Alpha thalassemia is caused by deficient production of the alpha globin component of hemoglobin, while beta thalassemia is a deficiency in the beta globin component. [7] The severity of alpha and beta thalassemia depends on how many of the four genes for alpha globin or two genes for beta globin are faulty. [2]
Patients with beta thalassemia minor are usually asymptomatic and are often monitored without treatment. [8] Beta thalassemia minor may coexist with other conditions such as chronic hepatitis B, chronic hepatitis C, non-alcoholic fatty liver disease and alcoholic liver disease that, when combined or co-existing, may cause a person to have iron ...
Betibeglogene autotemcel, sold under the brand name Zynteglo, is a gene therapy for the treatment for beta thalassemia. [1] [5] [2] It was developed by Bluebird Bio and was given breakthrough therapy designation by the US Food and Drug Administration in February 2015.
Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. [5] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [8]
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: thalassemia beta minor treatment side effects